Calendrier des promotions Biotricity, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
| Цена ао |
1.33 |
| Выручка |
0.000398 |
| EBITDA |
-1.2E-5 |
| P/S |
76.27 |
| P/BV |
-17.09 |
| EV/EBITDA |
-2671.72 |
| ISIN |
US09074H1041 |
| Число акций ао |
0.00866 млрд |
| Сайт |
https://www.biotricity.com
|
| Валюта |
usd |
| IPO date |
2016-02-18 |
| Sector |
Health Care |
| Industry |
Health Care Equipment & Supplies |
| Валюта отчета |
usd |
| Changement de prix par jour: |
+1.72% (0.2556) |
| Changement de prix par semaine: |
0% (0.26) |
| Changement de prix par mois: |
-20.49% (0.327) |
| Changement de prix sur 3 mois: |
-69.19% (0.844) |
| Changement de prix sur six mois: |
-80.74% (1.35) |
| Changement de prix par an: |
-87.85% (2.14) |
| Evolution du prix sur 3 ans: |
-90.58% (2.76) |
| Evolution du prix sur 5 ans: |
-55.93% (0.59) |
| Evolution des prix depuis le début de l'année: |
-70.45% (0.88) |
|
|
Sous-estimation
| Nom |
Signification |
Grade |
| P/S |
1 |
9 |
| P/BV |
-0.4031 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
-2.82 |
0 |
| Total: |
|
4.63 |
|
Efficacité
| Nom |
Signification |
Grade |
| ROA, % |
-237.17 |
0 |
| ROE, % |
47.02 |
10 |
| Total: |
|
5 |
|
|
|
Dividendes
| Nom |
Signification |
Grade |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Total: |
|
0 |
|
Devoir
| Nom |
Signification |
Grade |
| Debt/EBITDA |
-1.47 |
10 |
| Total: |
|
6.6 |
|
Impulsion de croissance
| Nom |
Signification |
Grade |
| Rentabilité Revenue, % |
761.67 |
10 |
| Rentabilité Ebitda, % |
81.23 |
9 |
| Rentabilité EPS, % |
378.63 |
10 |
| Total: |
|
6.6 |
|
| Superviseur |
Titre d'emploi |
Paiement |
Année de naissance |
| Dr. Waqaas Al-Siddiq Ph.D. |
Founder, President, CEO & Chairman |
732k |
1985 (39 années) |
| Mr. S. John Ayanoglou |
Chief Financial Officer |
305.75k |
1966 (58 années) |
| Dr. George N. Nikopoulos |
Director of Business Development |
N/A |
|
| Mr. Matt Zabel |
Vice President of Sales & Strategy |
N/A |
|
| Mr. Amir Ali |
Chief Development Officer |
N/A |
|
| Amjad Talpur |
Senior Director of Operations |
|
|
| Dr. Fareeha Siddiqui |
Senior Vice President of Healthcare Solutions |
|
|
